Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2013

01.12.2013 | Basic Science

Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro

verfasst von: Jiong Wang, Tanja Stachon, Timo Eppig, Achim Langenbucher, Berthold Seitz, Nóra Szentmáry

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Photodynamic inactivation (PDI) may be a potential alternative in cases of therapy-resistant infectious keratitis. The purpose of our study was to determine the impact of PDI using the photosensitizer chlorin e6 (Ce6) on viability, apoptosis, and proliferation of human keratocytes, in vitro.

Methods

Primary human keratocytes were isolated by digestion in collagenase (1 mg/ml) from human corneal buttons, and cultured in DMEM/Ham’s F12 medium supplemented with 10 % FCS. Keratocyte cell cultures underwent illumination using red (670 nm) light for 13 min following exposure to 50 nM to 64 μM concentrations of Ce6 in the culture medium. Twenty-four hours after PDI, cell viability was evaluated by the Alamar blue assay, total DNA content of the cells and apoptosis using the APO-DIRECT™ Kit, and cell proliferation by the BrdU Cell Proliferation Assay Kit.

Results

Using Ce6 or illumination only, we did not detect significant changes of cell viability, apoptosis, and proliferation. Using illumination, viability of keratocytes decreased significantly above 100 nM (P < 0.01), and proliferation at 250 nM Ce6 concentration (P = 0.01) and the percentage of apoptotic keratocytes increased significantly at 500 nM (P < 0.01) concentration.

Conclusions

In the short term, photodynamic inactivation using Ce6 decreases viability and proliferation, and also triggers apoptosis of human keratocytes, in vitro.
Literatur
1.
Zurück zum Zitat Jones DB (1981) Decision-making in the management of microbial keratitis. Ophthalmology 88:814–820PubMedCrossRef Jones DB (1981) Decision-making in the management of microbial keratitis. Ophthalmology 88:814–820PubMedCrossRef
2.
Zurück zum Zitat Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905PubMedCrossRef Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905PubMedCrossRef
3.
Zurück zum Zitat Moore C, Wallis C, Melnick JL, Kuns MD (1972) Photodynamic treatment of herpes keratitis. Infect Immun 5:169–171PubMedCentralPubMed Moore C, Wallis C, Melnick JL, Kuns MD (1972) Photodynamic treatment of herpes keratitis. Infect Immun 5:169–171PubMedCentralPubMed
4.
Zurück zum Zitat Ito T (1981) Photodynamic action of hematoporphyrin on yeast cells - a kinetic approach. Photochem Photobiol 34:521–524 Ito T (1981) Photodynamic action of hematoporphyrin on yeast cells - a kinetic approach. Photochem Photobiol 34:521–524
5.
Zurück zum Zitat Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G (2013) Riboflavin/ultraviolet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 97:669–671PubMedCrossRef Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G (2013) Riboflavin/ultraviolet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 97:669–671PubMedCrossRef
6.
Zurück zum Zitat Fimple JL, Fontana CR, Foschi F, Ruggiero K, Song X, Pagonis TC, Tanner AC, Kent R, Doukas AG, Stashenko PP, Soukos NS (2008) Photodynamic treatment of endodontic polymicrobial infection in vitro. J Endod 34:728–734PubMedCentralPubMedCrossRef Fimple JL, Fontana CR, Foschi F, Ruggiero K, Song X, Pagonis TC, Tanner AC, Kent R, Doukas AG, Stashenko PP, Soukos NS (2008) Photodynamic treatment of endodontic polymicrobial infection in vitro. J Endod 34:728–734PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402–3408PubMedCrossRef Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402–3408PubMedCrossRef
8.
Zurück zum Zitat Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118:324–331PubMedCrossRef Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118:324–331PubMedCrossRef
9.
Zurück zum Zitat Goto B, Iriuchishima T, Horaguchi T, Tokuhashi Y, Nagai Y, Harada T, Saito A, Aizawa S (2011) Therapeutic effect of photodynamic therapy using Na-pheophorbide a on osteomyelitis models in rats. Photomed Laser Surg 29:183–189PubMedCrossRef Goto B, Iriuchishima T, Horaguchi T, Tokuhashi Y, Nagai Y, Harada T, Saito A, Aizawa S (2011) Therapeutic effect of photodynamic therapy using Na-pheophorbide a on osteomyelitis models in rats. Photomed Laser Surg 29:183–189PubMedCrossRef
10.
Zurück zum Zitat Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW (1988) In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J Natl Cancer Inst 80:330–336PubMedCrossRef Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW (1988) In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J Natl Cancer Inst 80:330–336PubMedCrossRef
11.
Zurück zum Zitat Kostenich GA, Zhuravkin IN, Furmanchuk AV, Zhavrid EA (1993) Sensitivity of different rat tumour strains to photodynamic treatment with chlorin e6. J Photochem Photobiol B 17:187–194PubMedCrossRef Kostenich GA, Zhuravkin IN, Furmanchuk AV, Zhavrid EA (1993) Sensitivity of different rat tumour strains to photodynamic treatment with chlorin e6. J Photochem Photobiol B 17:187–194PubMedCrossRef
12.
Zurück zum Zitat Kostenich GA, Zhuravkin IN, Zhavrid EA (1994) Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors. J Photochem Photobiol B 22:211–217PubMedCrossRef Kostenich GA, Zhuravkin IN, Zhavrid EA (1994) Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors. J Photochem Photobiol B 22:211–217PubMedCrossRef
13.
Zurück zum Zitat Moon YH, Kwon SM, Kim HJ, Jung KY, Park JH, Kim SA, Kim YC, Ahn SG, Yoon JH (2009) Efficient preparation of highly pure chlorin e6 and its photodynamic anti-cancer activity in a rat tumor model. Oncol Rep 22:1085–1091PubMed Moon YH, Kwon SM, Kim HJ, Jung KY, Park JH, Kim SA, Kim YC, Ahn SG, Yoon JH (2009) Efficient preparation of highly pure chlorin e6 and its photodynamic anti-cancer activity in a rat tumor model. Oncol Rep 22:1085–1091PubMed
14.
Zurück zum Zitat Wang J, Stachon T, Eppig T, Langenbucher A, Seitz B, Szentmary N (2013) Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human corneal endothelial cells. Graefes Arch Clin Exp Ophthalmol 251:1199–1204PubMedCrossRef Wang J, Stachon T, Eppig T, Langenbucher A, Seitz B, Szentmary N (2013) Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human corneal endothelial cells. Graefes Arch Clin Exp Ophthalmol 251:1199–1204PubMedCrossRef
15.
Zurück zum Zitat Seitz B, Hayashi S, Wee WR, LaBree L, McDonnell PJ (1996) In vitro effects of aminoglycosides and fluoroquinolones on keratocytes. Invest Ophthalmol Vis Sci 37:656–665PubMed Seitz B, Hayashi S, Wee WR, LaBree L, McDonnell PJ (1996) In vitro effects of aminoglycosides and fluoroquinolones on keratocytes. Invest Ophthalmol Vis Sci 37:656–665PubMed
16.
Zurück zum Zitat Cubitt CL, Tang Q, Monteiro CA, Lausch RN, Oakes JE (1993) IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 34:3199–3206PubMed Cubitt CL, Tang Q, Monteiro CA, Lausch RN, Oakes JE (1993) IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 34:3199–3206PubMed
17.
Zurück zum Zitat Finke M, Bleses K, Winkler K, Wang J, Szentmáry N, Eppig T, Foth H-J, Hüttenberger D, Langenbucher A, Seitz B, Bischoff M (2012) Die photodynamische Therapie: eine neue Perspektive für die Behandlung der bakteriell induzierten infektiösen Keratitis. Ophthalmologe 109(suppl 1):59, abstract PDo06-046 Finke M, Bleses K, Winkler K, Wang J, Szentmáry N, Eppig T, Foth H-J, Hüttenberger D, Langenbucher A, Seitz B, Bischoff M (2012) Die photodynamische Therapie: eine neue Perspektive für die Behandlung der bakteriell induzierten infektiösen Keratitis. Ophthalmologe 109(suppl 1):59, abstract PDo06-046
18.
Zurück zum Zitat Wong TW, Tracy E, Oseroff AR, Baumann H (2003) Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Res 63:3812–3818PubMed Wong TW, Tracy E, Oseroff AR, Baumann H (2003) Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Res 63:3812–3818PubMed
19.
Zurück zum Zitat Oleinick NL, Morris RL, Belichenko I (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1:1–21PubMedCrossRef Oleinick NL, Morris RL, Belichenko I (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 1:1–21PubMedCrossRef
20.
Zurück zum Zitat Lavie G, Kaplinsky C, Toren A, Aizman I, Meruelo D, Mazur Y, Mandel M (1999) A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 79:423–432PubMedCentralPubMedCrossRef Lavie G, Kaplinsky C, Toren A, Aizman I, Meruelo D, Mazur Y, Mandel M (1999) A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 79:423–432PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Kessel D, Poretz RD (2000) Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME). Photochem Photobiol 71:94–96PubMedCrossRef Kessel D, Poretz RD (2000) Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME). Photochem Photobiol 71:94–96PubMedCrossRef
22.
Zurück zum Zitat Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100:44–49PubMedCrossRef Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100:44–49PubMedCrossRef
23.
Zurück zum Zitat Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250:95–102PubMedCrossRef Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250:95–102PubMedCrossRef
24.
Zurück zum Zitat Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW Jr (2012) Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28:706–713PubMedCrossRef Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW Jr (2012) Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28:706–713PubMedCrossRef
25.
Zurück zum Zitat Wollensak G, Spoerl E, Reber F, Seiler T (2004) Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye (Lond) 18:718–722CrossRef Wollensak G, Spoerl E, Reber F, Seiler T (2004) Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye (Lond) 18:718–722CrossRef
26.
Zurück zum Zitat Mencucci R, Marini M, Paladini I, Sarchielli E, Sgambati E, Menchini U, Vannelli GB (2010) Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol 38:49–56CrossRef Mencucci R, Marini M, Paladini I, Sarchielli E, Sgambati E, Menchini U, Vannelli GB (2010) Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol 38:49–56CrossRef
Metadaten
Titel
Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro
verfasst von
Jiong Wang
Tanja Stachon
Timo Eppig
Achim Langenbucher
Berthold Seitz
Nóra Szentmáry
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 12/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2470-9

Weitere Artikel der Ausgabe 12/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.